“The decrease was driven by a reduction in interest expense due to lower debt and a reduction in the interest rate.”10-Q · May 8, 2026 ↗
TruBridge Inc
TBRG
Market read
TruBridge Inc's move is being confirmed by its market group.
No new filing conclusion is available. 6 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.
- At least 5 of 7 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as BG begins moving with the group.
Invalidation: The live read weakens if participation falls to 2 of 7 members or fewer.
Research brief
The story so far
No new filing conclusion is available. 6 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- At least 5 of 7 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as BG begins moving with the group.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Operating margin changed +4.1 percentage points in the latest annual period.
- Net margin changed +7.4 percentage points in the latest annual period.
- Operating cash flow covered net income at 8.49x in the latest annual period.
- Credit and interest rates has repeated adverse evidence across 4 filings.
- Input and raw-material costs has repeated adverse evidence across 4 filings.
- Labor availability and costs has repeated adverse evidence across 4 filings.
- Product pipeline and R&D has repeated adverse evidence across 3 filings.
- P/E is 84% above the available filing-peer median; determine whether growth and quality justify the difference.
- EV/sales is 46% below the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Jul 13, 2026
26.24Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“Bookings are reported on an Annual Contract Value (“ACV”) basis and represent the newly contracted revenue that is expected to be recognized over a twelve-month period, and were as follows for the three months ended March 31, 2026 and 2025: Three Months Ended…”10-Q · May 8, 2026 ↗
“Costs associated with our Patient Care revenues decreased by $1.2 million, or 10%, compared to the first quarter of 2025, primarily due to a reduction in software costs and lower labor costs as a result of cost optimization and savings efforts.”10-Q · May 8, 2026 ↗
“Costs associated with our Patient Care revenues decreased by $1.2 million, or 10%, compared to the first quarter of 2025, primarily due to a reduction in software costs and lower labor costs as a result of cost optimization and savings efforts.”10-Q · May 8, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 1.1× · EV/sales 1.5×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 8 Jul, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for TBRG. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for TBRG. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind TBRG
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
SOLVSolventum CorporationcompetitorMar 31, 2026 ▾
“The primary competitors for our encoder solutions include Solventum and Optum.”
WAYWaystar Holding Corp.competitorMar 31, 2026 ▾
“Our principal competitors for Financial Health solutions include RelayHealth Corp, SSI Group, LLC, Quadax Inc., Change Healthcare Holdings, Inc., Availity, LLC, Waystar Technologies, Inc., Experian, and Navicure, Inc.”
XTNDFiling-linked namecompetitorMar 31, 2026 ▾
“Our principal competitors in the business management, consulting and managed IT services market are Resolution Health, Inc., The Outsource Group Inc., Patient Focus, Inc., Xtend Healthcare Inc., Ensemble Health Partners, and FinThrive, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
TBRG is currently a Participant in the organic co-movement group Diversified Financial Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.